Author: Customer Service

CrossAmerica Partners to Announce Third Quarter 2026 Earnings Results on November 4

Written by Customer Service on October 16, 2026. Posted in Public Companies.

Allentown, PA, Oct. 16, 2026 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce Third Quarter 2026 Earnings Results on November 4 ALLENTOWN, PA, October 16, 2026 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its third quarter 2026 results after the market closes on Wednesday, November 4, 2026. In conjunction with the news release, management will host a conference call on Thursday, November 5, at 9:00 a.m. Eastern Time. In order to listen to the conference call, please dial 800-717-1738 or 646-307-1865 and the passcode for both is 301276. An audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section...

San Lorenzo Announces Private Placement of Up to $40 Million

Written by Customer Service on October 16, 2026. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Oct. 16, 2026 (GLOBE NEWSWIRE) — San Lorenzo Gold Corp. (“San Lorenzo” or the “Company”) (TSXV: SLG; OTC: SNLGF) is pleased to announce a best-efforts private placement of up to 7,547,200 common shares of the Company (the “Offered Shares“) at a price of $5.30 per Offered Share (the “Issue Price“) for aggregate gross proceeds of up to $40,000,160 (the “Offering“). The Offering will be led by SCP Resource Finance LP, as lead agent (the “Lead Agent“), on behalf of a syndicate of agents (together with the Lead Agent, the “Agents”). The Offering will consist of: (a) up to 3,773,600 Offered Shares (the “LIFE Shares“) for aggregate gross proceeds of up to $20,000,080...

Form 8.3 – [GOOCH & HOUSEGO PLC – 15 10 2026] – (CGWL)

Written by Customer Service on October 16, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 15 10 2026] – (CGWL)

Written by Customer Service on October 16, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

FERRARI TO ANNOUNCE THIRD QUARTER 2026 FINANCIAL RESULTS ON NOVEMBER 3

Written by Customer Service on October 16, 2026. Posted in Public Companies.

Maranello (Italy), October 16, 2026 – Ferrari N.V. (“Ferrari”) (NYSE/EXM: RACE) announced today that its financial results for the third quarter of 2026 will be released on Tuesday, November 3, 2026. A live audio webcast and conference call of the 2026 Q3 results will begin at 2:00 p.m. GMT / 3:00 p.m. CET / 9:00 a.m. EST on Tuesday, November 3. Details for accessing this presentation will be available in the Investors section of Ferrari’s corporate website at https://www.ferrari.com/en-EN/corporate prior to the event. Please note that registering in advance is required to access the conference call details. For those unable to participate in the live session, a replay will remain archived on Ferrari’s corporate website (https://www.ferrari.com/en-EN/corporate) for two weeks after the call. For further information:Media RelationsEmail:...

ONERugged Launches V82T and M10A-VDS Rugged Devices for Fleet Management and Vehicle Diagnostics

Written by Customer Service on October 16, 2026. Posted in Public Companies.

SHENZHEN, China, Oct. 16, 2026 (GLOBE NEWSWIRE) — As fleets grow larger and vehicles become more connected, electrified, and software-driven, operators face two converging challenges: keeping real-time visibility over dispersed vehicles, and diagnosing increasingly sophisticated vehicle electronics. ONERugged, a brand of Emdoor Information (SZ:001314), has launched a new connected ecosystem of rugged, purpose-built devices — the V82T vehicle-mounted computer for fleet management and the M10A-VDS Vehicle Diagnostic Tablet Solution for smart automotive diagnostics — to answer both. From Manual Processes to Data-Driven Operations Across logistics, transportation, manufacturing, and public transit, operators are managing fleets of rising scale and complexity. Beyond handling high order volumes, they must maintain real-time visibility...

Li Auto Inc. Announces Equity Financing for Its Chip Business

Written by Customer Service on October 16, 2026. Posted in Public Companies.

BEIJING, China, Oct. 16, 2026 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that Shanghai Mahe Xin Technology Co., Ltd. (“MHX Technology”), a subsidiary of the Company dedicated to its chip and domain controller business, entered into subscription agreements for equity financing totaling RMB1.625 billion (the “Subscription”). The Company, through a wholly-owned subsidiary, and external investors including Hangzhou Jingtao, Lanchi Ventures, Huaye Tiancheng and MiraclePlus (the “Investors”) will invest RMB1.0 billion and RMB625 million respectively. In addition, Hangzhou Jingtao Additional Investor has been granted a right (“Hangzhou Jingtao Subscription Right”), on a one-off basis on or before December 31, 2026, to invest in MHX...

Update on Ontex Russia

Written by Customer Service on October 16, 2026. Posted in Earnings Releases And Operating Results.

Aalst, Belgium, October 16, 2026 – Ontex Group NV [EURONEXT: ONTEX] has been informed of a Russian Presidential Decree dated October 15, 2026, pursuant to which Ontex’s local subsidiary, Ontex Russia, has been placed under interim administration. Under such procedure, a government-appointed interim administrator has assumed operational control of Ontex Russia. Ontex Russia currently employs around 350 employees and operates a production facility in Noginsk and sales office in Moscow. Ontex Russia represents about 5% of the total revenue of Ontex Group, 7 to 8% of adj. EBITDA under IFRS consolidation rules and provides limited cash contribution. Ontex is investigating the situation and will consider appropriate actions to safeguard its assets and the continuity of Ontex Russia’s operations, in the interest of its employees and other stakeholders. EnquiriesInvestors Geoffroy...

Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology

Written by Customer Service on October 16, 2026. Posted in Public Companies.

BEIJING, Oct. 16, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of orelabrutinib, its novel BTK inhibitor, have been selected for oral presentations at the 88th Annual Meeting of the Japanese Society of Hematology (JSH 2026). The studies focused on real-world data of orelabrutinib monotherapy for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL), preliminary Phase II results of an orelabrutinib regimen as first-line treatment for marginal zone lymphoma (MZL), as well as Phase II results of an orelabrutinib regimen as first-line treatment for diffuse large B cell lymphoma (DLBCL). Professor Huayuan Zhu from Jiangsu Provincial Hospital, and professor Wenyu Shi from...

AB Tewox publishes its factsheet for Q3 2026

Written by Customer Service on October 16, 2026. Posted in Public Companies.

Vilnius, Lithuania, Oct. 16, 2026 (GLOBE NEWSWIRE) — SUTNTIB AB Tewox publishes its factsheet, providing information about financial indicators as of 30 September 2026 and key events for the quarter. 2026 Q3 key events:On 13 July 2026, the Bank of Lithuania approved Tewox’s base prospectus, pursuant to which the company intends to publicly offer and issue bonds with a total nominal value of up to EUR 50 million (ISIN LT0000138281) and to admit them to trading on the Nasdaq Baltic regulated market. On 21 August 2026, the first tranche of EUR 17.4 million under the base prospectus for up to EUR 50 million of bonds was issued (ISIN LT0000138281) and admitted to trading on the Nasdaq Baltic regulated market. Tewox published its unaudited interim consolidated and separate financial statements for the six-month period ended 30 June...

Author: Customer Service

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals